×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Company: AD Neuroimmune Checkpoint and TREM2 Pathway Companies
company
1,640 words
KG: Ad
2026-03-29
kind:company
section:companies
state:published
topic:alzheimers
topic:trem2
topic:neuroinflammation
topic:neuroimmune-checkpoint
Contents
AD Neuroimmune Checkpoint and TREM2 Pathway Companies
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener
Score: 0.61
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming
Score: 0.59
TREM2-SIRT1 Metabolic Senescence Circuit in Microglial Aging
Score: 0.59
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.59
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.58
Purinergic Signaling Polarization Control
Score: 0.55
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular
Score: 0.53
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Microglial TREM2 downregulation impairs damage-associated re
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Disease-Associated Microglia Metabolic Reprogramming
Score: 0.50
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid
Score: 0.49
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio
Score: 0.49
APOE-TREM2 Interaction Modulation
Score: 0.48
Oligodendrocyte Remyelination Enhancement
Score: 0.47
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Peripheral-Central Immune Decoupling Therapy
Score: 0.46
TREM2-Mediated Microglial Checkpoint Therapy
Score: 0.46
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in
Score: 0.46
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in
Score: 0.46
TREM2 R47H Variant Correction — AAV-Mediated Rescue of Commo
Score: 0.45
TREM2-Dependent Microglial Surveillance Controls AQP4-Mediat
Score: 0.45
TREM2-Mediated Microglial Dysfunction Disrupts Oligodendrocy
Score: 0.45
Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Pha
Score: 0.45
TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR
Score: 0.45
Show 25 more
Related Analyses (30)
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
Neuroinflammation and microglial priming in early AD
neurodegeneration · completed
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
Mechanistic validation of SEA-AD differential expression hyp
neurodegeneration · failed
Do these mechanistic hypotheses explain layer-specific synap
neurodegeneration · failed
Do these mechanistic hypotheses from the SEA-AD Atlas bundle
neurodegeneration · failed
What are the optimal temporal windows for TREM2 inhibition v
neurodegeneration · failed
What are the optimal timing windows for TREM2 inhibition vs
neurodegeneration · failed
Does SYK activation provide neuroprotection or exacerbate ne
neurodegeneration · failed
Can TREM2 receptor switching from agonism to antagonism be a
neurodegeneration · failed
What are the optimal timing windows for TREM2 agonism vs ant
neurodegeneration · failed
Can biased TREM2 agonists selectively activate DAP12-SYK-PI3
molecular biology · failed
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
Show 25 more
Related Experiments (4)
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.46
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.46
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.46
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.46
See Also (15)
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 6 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 6 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 6 hypotheses
Sex Differences in Neurodegeneration
mechanism · Pages share 6 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 6 hypotheses
Retinal Degeneration Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
Microglial Priming Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 6 hypotheses
IL-1 Signaling Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
HMGB1 Signaling in Neurodegeneration
mechanism · Pages share 6 hypotheses
gp130/IL-6 Family Cytokine Signaling in Neurodegenerati
mechanism · Pages share 6 hypotheses
Geniposide for Alzheimer's disease - immune biomarker t
mechanism · Pages share 6 hypotheses
Galectin-3 Mechanism in Neurodegeneration
mechanism · Pages share 6 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
Dystrophic Neurites in Neurodegeneration
mechanism · Pages share 6 hypotheses
Show 10 more
Knowledge Graph (1 edges)
TDP-43
associated_with
Ad